aTyr Pharma (LIFE) Tops Q2 EPS by 6c

aTyr Pharma (NASDAQ: LIFE) reported Q2 EPS of ($0.22), $0.06 better than the analyst estimate of ($0.28).

For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• Casey's General Stores (CASY) Tops Q1 EPS by 69c
• ServiceTitan, Inc. (TTAN) Misses Q2 EPS by 1c, Offers Guidance